Mass Balance Study

13 drugs in development·2 companies·2 clinical trials

Drug Pipeline by Phase

Phase 3(10)

Drug	Company
hmpl-306	HUTCHMED (China) Limited (HCM)
hmpl-306 regimen	HUTCHMED (China) Limited (HCM)
hmpl-453	HUTCHMED (China) Limited (HCM)
hmpl-453	HUTCHMED (China) Ltd (HMDCF)
hmpl-506	HUTCHMED (China) Limited (HCM)
hmpl-523	HUTCHMED (China) Limited (HCM)
hmpl-689	HUTCHMED (China) Limited (HCM)
hmpl-a251	HUTCHMED (China) Limited (HCM)
hmpl-a580	HUTCHMED (China) Limited (HCM)
hmpl-a83	HUTCHMED (China) Limited (HCM)

Phase 1(3)

Drug	Company
100 µci [14c] hmpl-306	HUTCHMED (China) Ltd (HMDCF)
100 µci [14c] hmpl-306	HUTCHMED (China) Limited (HCM)
hmpl-453	HUTCHMED (China) Limited (HCM)

Compare drugs

hmpl-306 vs hmpl-306 regimen hmpl-306 vs hmpl-453 hmpl-306 vs hmpl-506

Frequently asked questions

How many drugs are in development for Mass Balance Study?

BioSniper tracks 13 drugs in development for Mass Balance Study across 2 companies.

How many clinical trials target Mass Balance Study?

There are 2 clinical trials targeting Mass Balance Study tracked by BioSniper.

Deep-dive into Mass Balance Study

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis

Mass Balance Study — Drugs in Development & Clinical Trials | BioSniper